The difference between a transaction and a transformation matters. Short Answer: When comparing providers, look beyond the medication. While Amazon's GLP-1 program through One Medical covers prescription access, clinical monitoring, and same-day medication delivery, ensure your choice includes dedicated nutrition counseling, support groups and muscle maintenance, as these are essential to preventing weight regain and […]
The FDA approved Foundayo™ (orforglipron) on April 1, 2026 — a new once-daily GLP-1 weight loss pill from Eli Lilly. If you've been curious about GLP-1 medications but not looking for weekly injections, here’s what you need to know about the newest oral version. Key Takeaways What Is Foundayo™ and How Does it Work? Foundayo™ […]
If you've started a GLP-1 medication like Wegovy® or Zepbound® and you're wondering whether bariatric surgery is still on the table — the short answer is yes. Starting with medication does not close the door to surgery. In fact, for patients at New Jersey Bariatric Center®, the path to lasting results isn't a single choice. […]
Is Pork Roll Egg and Cheese a healthy choice while on a GLP-1? While a traditional NJ breakfast sandwich is high in sodium and fat—which can trigger nausea and bloating on Wegovy® or Zepbound®—Registered Dietitian Dana recommends a high-protein, low-carb Healthy Breakfast Bake alternative to satisfy cravings without the side effects. If you've ever grabbed […]
The FDA-Approved Oral GLP-1 Wegovy® Weight Loss Pill is Now Available in New Jersey The Wegovy® Pill for weight loss is now available throughout New Jersey after receiving FDA approval on December 22, 2025. For patients who have avoided weight loss injections due to needle-anxiety or those managing weekly injections this once-daily GLP-1 pill offers […]
How to Navigate Eating Schedules, Meal Prep & Social Dining While on Weight Loss Medications and Injections By Karen Kelly, Registered Dietitian with more than 20 years of specialized experience in weight management and bariatric nutrition at New Jersey Bariatric Center® Medically Reviewed By: Alexis Begliomini, PA-C Key Takeaways GLP-1 medications eliminate the mental chatter […]
Nausea is a common side effect of GLP-1 weight loss medications like Ozempic®, Wegovy®, Zepbound® and Mounjaro®. It occurs due to delayed stomach emptying and the effect on appetite signals in the brain. Most nausea improves within 4-8 weeks as the body adjusts. Combat symptoms by starting with low doses, eating smaller meals, avoiding fatty […]
Updated on December 23, 2025 to include the FDA approval of the Wegovy®pill by Novo Nordisk. With FDA-approval of the Wegovy® pill by Novo Nordisk in December 2025, the first oral versions ofGLP-1 weight loss medications are scheduled to reach the market in January 2026. Eli Lilly’s weight loss pill, Orforglipron, is still awaiting FDA-approval […]
By Dana Babeu, Registered Dietitian with 14 years of specialized experience in weight management and bariatric nutrition at New Jersey Bariatric Center® Medically Reviewed by Ajay Goyal, MD, FACS Planning a vacation while taking semaglutide (Ozempic®, Wegovy®), tirzepatide (Mounjaro®, Zepbound®), or other GLP-1 medications? You are not alone. With more than 15 million Americans now […]
When we learned that tennis legend Serena Williams revealed she lost 31 pounds using GLP-1 weight loss medication, Zepbound®, we immediately thought of the countless mothers in our practice who've shared the same story - doing everything 'perfectly' but still unable to lose postpartum weight. Williams specifically cited her struggles after completing breastfeeding her daughters […]
Wegovy®, Saxenda®, and Qsymia® are FDA-Approved Prescription Weight Loss Medications Available to Weight Loss Patients in New Jersey Who Qualify With so many choices how do you know which medication is best for you? Here's some points to help you decide. Do I Qualify for Weight Loss Medications? First, determine if you meet the criteria […]
FDA Declares End to Semaglutide and Tirzepatide Shortage, Restricting Compounding Production of the GLP-1s for NJ Residents Using These Medications for Weight Loss May marks a significant transition for many people on weight loss medications across New Jersey. As the FDA's April 22nd deadline for many compounding pharmacies has passed and the May 22nd deadline […]


